GRYPHON BIO INC

SAN ANTONIO, TX, 78215

Prime contracting experience

1 record from government sources. Past participation is not evidence of current teaming interest.

Role	Agency	Description	Vehicle	Obligated	Action date	Period
Prime	Department of Defense Defense Health Agency	NEW RESEARCH AND DEVELOPMENT CONTRACT AWARD FOR THE FEASIBILITY STUDY OF A SINGLE PLATFORM SOLUTION FOR BLOOD TESTING OF TRAUMATIC BRAIN INJURY BIOMARKERS FOR THE CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAM OFFICE W81XWH22C0059USAspending	—	$749,437	Feb 10, 2026	Sep 26, 2022 – Jun 24, 2026

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Agencies supported

Department of DefenseGov-sourced

Is this your company?

Claim this profile for free to add your capabilities, teaming interests, capability statement link and employee count, and to report certifications for verification.

FedSub reviews every claim before granting access. Government-sourced data stays as published; your additions are labeled company-reported.

Claim this profile (free)

Identifiers

UEI: GNX8BTRL8915
CAGE: 84CH5
Website: www.gryphonbio.com

NAICS codes

541714Research and Development in Biotechnology (except Nanobiotechnology)Primary(definition)
541715Research and Development in the Physical, Engineering, and Life Sciences(definition)

Data sources

SAM.gov monthly extract
ID GNX8BTRL8915 · fetched Oct 25, 2026 · source
USAspending.gov
ID recipient:GNX8BTRL8915 · fetched Oct 25, 2026 · source

Last synced Oct 25, 2026 · profile updated Oct 25, 2026

Find similar contractors

Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.